RecruitingNCT06316544

China Elderly Comorbidity Medical Database


Sponsor

Beijing Friendship Hospital

Enrollment

4,100 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this observational cohort study is to provide comprehensive evaluation and early warning for elderly patients with chronic diseases. The main question it aims to answer is: How to explore effective evaluation methods for diseases in elderly patients based on the coexistence of multiple diseases and high individual heterogeneity? How to explore the key indicators and influencing factors of adverse events in elderly patients.. Participants will be followed up at 1, 3, 6, 9, and 12 months to obtain adverse event information.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This is a large observational database study in China enrolling elderly patients with multiple chronic conditions to track how different diseases interact and affect health outcomes over time. It is not testing a new treatment — it collects clinical data to help researchers better understand and manage complex health problems in older adults. **You may be eligible if...** - You are 65 years of age or older - You have at least one of the following conditions: high blood pressure, type 2 diabetes, coronary heart disease, osteoporosis, or chronic obstructive pulmonary disease (COPD) **You may NOT be eligible if...** - You are under 65 years old - You do not have any of the qualifying chronic conditions listed above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Friendship Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06316544


Related Trials